Literature DB >> 22797746

Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

Wafaa M El-Sadr1, Charles B Holmes, Peter Mugyenyi, Harsha Thirumurthy, Tedd Ellerbrock, Robert Ferris, Ian Sanne, Anita Asiimwe, Gottfried Hirnschall, Rejoice N Nkambule, Lara Stabinski, Megan Affrunti, Chloe Teasdale, Isaac Zulu, Alan Whiteside.   

Abstract

Since its inception in 2003, the US President's Emergency Plan for AIDS Relief (PEPFAR) has been an important driving force behind the global scale-up of HIV care and treatment services, particularly in expansion of access to antiretroviral therapy. Despite initial concerns about cost and feasibility, PEPFAR overcame challenges by leveraging and coordinating with other funders, by working in partnership with the most affected countries, by supporting local ownership, by using a public health approach, by supporting task-shifting strategies, and by paying attention to health systems strengthening. As of September 2011, PEPFAR directly supported initiation of antiretroviral therapy for 3.9 million people and provided care and support for nearly 13 million people. Benefits in terms of prevention of morbidity and mortality have been reaped by those receiving the services, with evidence of societal benefits beyond the anticipated clinical benefits. However, much remains to be accomplished to achieve universal access, to enhance the quality of programs, to ensure retention of patients in care, and to continue to strengthen health systems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797746      PMCID: PMC3445041          DOI: 10.1097/QAI.0b013e31825eb27b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  35 in total

1.  Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea.

Authors:  Mit Philips; Rony Zachariah; Sarah Venis
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

Review 2.  Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening.

Authors:  Denis Nash; Batya Elul; Miriam Rabkin; May Tun; Suzue Saito; Mark Becker; Harriet Nuwagaba-Biribonwoha
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11       Impact factor: 3.731

Review 3.  Economic impact of HIV.

Authors:  Nina Veenstra; Alan Whiteside
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-12-13       Impact factor: 5.237

4.  AIDS Treatment and Intrahousehold Resource Allocation: Children's Nutrition and Schooling in Kenya.

Authors:  Joshua Graff Zivin; Harsha Thirumurthy; Markus Goldstein
Journal:  J Public Econ       Date:  2009-08-01

5.  Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.

Authors:  S M Hermans; F van Leth; Y C Manabe; A I M Hoepelman; J M A Lange; A Kambugu
Journal:  HIV Med       Date:  2012-02-02       Impact factor: 3.180

Review 6.  Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review.

Authors:  Jennifer Beard; Frank Feeley; Sydney Rosen
Journal:  AIDS Care       Date:  2009-11

7.  Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment.

Authors:  Alana T Brennan; Lawrence Long; Mhairi Maskew; Ian Sanne; Imogen Jaffray; Patrick MacPhail; Matthew P Fox
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

8.  Economic returns to investment in AIDS treatment in low and middle income countries.

Authors:  Stephen Resch; Eline Korenromp; John Stover; Matthew Blakley; Carleigh Krubiner; Kira Thorien; Robert Hecht; Rifat Atun
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

9.  Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.

Authors:  Shabbar Jaffar; Barbara Amuron; Susan Foster; Josephine Birungi; Jonathan Levin; Geoffrey Namara; Christine Nabiryo; Nicaise Ndembi; Rosette Kyomuhangi; Alex Opio; Rebecca Bunnell; Jordan W Tappero; Jonathan Mermin; Alex Coutinho; Heiner Grosskurth
Journal:  Lancet       Date:  2009-11-24       Impact factor: 79.321

10.  Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya.

Authors:  Rachel C Vreeman; Winstone M Nyandiko; Edwin Sang; Beverly S Musick; Paula Braitstein; Sarah E Wiehe
Journal:  Confl Health       Date:  2009-04-04       Impact factor: 2.723

View more
  47 in total

1.  Massive benefits of antiretroviral therapy in Africa.

Authors:  Sten H Vermund
Journal:  J Infect Dis       Date:  2013-12-03       Impact factor: 5.226

Review 2.  Implementation challenges for long-acting antivirals as treatment.

Authors:  Diane Havlir; Monica Gandhi
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

Review 3.  Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.

Authors:  Clement A Adebamowo; Corey Casper; Kishor Bhatia; Sam M Mbulaiteye; Annie J Sasco; Warren Phipps; Sten H Vermund; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

4.  Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.

Authors:  Cynthia Riviere; Elizabeth Faust; Thane Miller; Eduard J Beck; Elaine Baruwa; Patrice Severe; Karine Severe; Claudia Thomas Riché; Rachelle Cassagnol; Sidney Atwood; Morgan Esperance; Lauren Webster; Pierre Cremieux; Jean W Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

5.  Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa.

Authors:  Ritu Shrivastava; Renuka Gadde; John N Nkengasong
Journal:  J Infect Dis       Date:  2016-04-15       Impact factor: 5.226

Review 6.  Past and Future Performance: PEPFAR in the Landscape of Foreign Aid for Health.

Authors:  Eran Bendavid
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

7.  Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.

Authors:  Mark J Siedner
Journal:  J Aging Health       Date:  2017-08-23

8.  Caught in the middle: the contested politics of HIV/AIDS and health policy in Vietnam.

Authors:  Jennifer S Hirsch; Le Minh Giang; Richard G Parker; Le Bach Duong
Journal:  J Health Polit Policy Law       Date:  2014-12-05       Impact factor: 2.265

9.  Population health and individualized care in the global AIDS response: synergy or conflict?

Authors:  Wafaa M El-Sadr; Miriam Rabkin; Kevin M DeCock
Journal:  AIDS       Date:  2016-09-10       Impact factor: 4.177

10.  Gender Differences and Psychosocial Factors Associated with Quality of Life Among ART Initiators in Oromia, Ethiopia.

Authors:  Quynh T Vo; Susie Hoffman; Denis Nash; Wafaa M El-Sadr; Olga A Tymejczyk; Tsigereda Gadisa; Zenebe Melaku; Sarah G Kulkarni; Robert H Remien; Batya Elul
Journal:  AIDS Behav       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.